Nexa Orthopedics, Inc. is focused on developing innovative products to meet the unmet clinical needs of the extremity surgeon.
New York, NY, USA and Grenoble, France, November 28, 2005 -- Nexa Orthopedics, Inc., ("Nexa") a HealthpointCapital portfolio company, announced today the acquisition of BIOProfile S.A. ("BIOProfile"). BIOProfile is the only company that both manufactures and distributes pyrolytic carbon orthopedic implants in the world. Pyrolytic carbon is a highly inert biomaterial technology providing beneficial properties for joint replacement applications.
"Joining Nexa will provide Bioprofile an excellent opportunity to launch its unique Pyrocarbon implants in the US market", said Cecile REAL, Chairman and CEO of BIOProfile.
"BIOProfile's pyrolytic carbon manufacturing and engineering expertise is an excellent fit with our product strategy and commercialization capabilities." said Paul Nichols, President and CEO, Nexa Orthopedics, Inc. "Along with an outstanding team in Grenoble, we also acquire a European sales and distribution network for Nexa's current and future product range."
"BIOProfile represents an exciting investment opportunity and provides a significant differentiating technology for Nexa", said Mortimer (Tim) Berkowitz III, HealthpointCapital President and Managing Director. "The acquisition is an important milestone in Nexa's emergence as a global leader in extremities surgery. It represents HealthpointCapital's second investment in France and reflects the Firm's commitment to invest in the most important and innovative orthopedic device companies in Europe." In June 2004, HealthpointCapital invested in Scient'x S.A., a leading independent spinal implant company (Guyancourt, France) (www.scient-x.com and www.scientxusa.com).
About Nexa Orthopedics, Inc.
Nexa Orthopedics, Inc. was founded in 2004 by HealthpointCapital to create the pre-eminent company in extremities surgery through a program of business investments, technology in-licensing and internal development. Paul Nichols, Nexa President and CEO, has 15 years experience in extremities orthopedics as both an executive and entrepreneur, including founding both Avanta Orthopaedics Corporation and Futura Biomedical, LLC.
About HealthpointCapital
HealthpointCapital Partners II, L.P. is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital has $500 million of institutional capital under management.
Where to Find Additional Information
SOURCE
HealthpointCapital, LLC.
CONTACT:
Media, John Foster, (212)810-4723,
jfoster@HealthpointCapital.com
or Tim Berkowitz, (212)810-4707,
tberkowitz@HealthpointCapital.com,
both of
HealthpointCapital;
or Paul Nichols of Nexa Orthopedics, Inc. (800)835-8480,
paulnichols@nexaortho.com.
Web sites www.pyrocarbon.com, www.nexaortho.com and
www.HealthpointCapital.com.
